The CD13/CD33+ group showed differential B‐ALL subtypes with a higher common‐B proportion (p = 0.001), lower level of lactate dehydrogenase (LDH) (p = 0.030) and higher positivity ratio of CD34 (p < 0.001). This evidence concerns the gene CD33 and acute lymphoblastic leukemia.